Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction

NCT02803073 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2019-11-21

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of testosterone replacement in hypogonadal men on exercise tolerance and cardiac rehabilitation after an acute myocardial infarction.

Conditions

  • Hypogonadism
  • Acute Myocardial Infarction: Rehabilitation Phase

Interventions

DRUG

Testosterone

Testosterone Cypionate Intramuscular injections will be administered weekly

DRUG

Normal Saline

Normal Saline Intramuscular injections will be administered weekly

Sponsors & Collaborators

  • Texas Tech University Health Sciences Center

    lead OTHER

Principal Investigators

  • Osama Mukarram, MD · Texas Tech University Health Sciences Center

  • Craig W Spellman, DO · Texas Tech University Health Sciences Center

  • Sandeep Dhindsa, MD · Texas Tech University Health Sciences Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-03-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02803073 on ClinicalTrials.gov